Addiction Medicine Physicians and Care for Hepatitis C

成瘾医学医生和丙型肝炎护理

• 批准号: 6665458
• 负责人: Alain Harris Litwin
• 金额: $ 4.18万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-09-30 至 2006-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6665458
• 关键词: HIV infections; alcoholism /alcohol abuse; attitude; behavioral /social science research tag; clinical research; depression; drug addiction; health care referral /consultation; health surveys; hepatitis C; human subject; methadone; microorganism disease chemotherapy; patient care; physicians

DESCRIPTION (provided by applicant): Drug users are heavily and disproportionately affected by hepatitis C, yet they face numerous barriers to healthcare that place them at risk for substantially lower levels of hepatitis C care than non-drug users. Because of their continuous contact with individual drug users and their knowledge of and experience with the intricacies of their healthcare, physicians practicing addiction medicine are in a unique position to facilitate drug users' access to and success with hepatitis C treatment. However, no data exists to describe the knowledge, attitudes and experience of addiction medicine physicians regarding hepatitis C care for drug users. We propose to nationwide survey of over 800 physician members of the American Society of Addiction Medicine (ASAM). Non-ASAM physicians practicing medicine in methadone maintenance treatment programs New York State will also be surveyed and compared to ASAM members to determine the generalizability of findings derived from the latter cohort. The proposed study will address the following specific aims: Aim 1: To describe the knowledge of and attitudes towards eligibility guidelines for hepatitis C treatment among physicians in addiction medicine, and determine the association between these attitudes and the physicians' provision of hepatitis C treatment to DUs, either direct or by referral; Aim 2: To determine the association between provision of HIV care by physicians in addiction medicine and the provision of hepatitis C treatment to DUs, either direct or by referral; Aim 3: To determine the association between the availability of onsite primary medical care in drug treatment programs and provision of hepatitis C treatment to DUs, either direct or by referral, by physicians in addiction medicine. The survey will focus on physicians' knowledge and attitudes surrounding treatment eligibility criteria, such as duration of abstinence from drug and alcohol use and history of depression. It will query physicians about their experience with hepatitis C treatment for drug users, either by referral or by direct management themselves, and their access to treatment resources. It will also inquire about their clinical practice setting and their professional background. The proposed study will identify strengths and weaknesses in the delivery of hepatitis C healthcare by addiction medicine physicians to drug users, and it will focus on collecting data useful for the development of interventions designed to improve drug users' access to hepatitis C treatment. Data from this study will have relevance to both drug abuse treatment policy and clinical practice.

描述（由申请人提供）： 吸毒者受到丙型肝炎的严重和不成比例的影响，但是他们面临许多医疗保健障碍，使他们面临的丙型肝炎护理水平大大低于非药物使用者。由于他们与个人药物使用者的持续联系以及对医疗保健的复杂性的了解和经验，从事成瘾医学的医生处于独特的位置，可以促进吸毒者获得丙型肝炎治疗的机会和成功。但是，尚无数据来描述成瘾医学医师对吸毒者的知识，态度和经验。我们建议对美国成瘾医学学会（ASAM）的800多名医师成员进行全国调查。在美沙酮维护治疗计划中执业医学的非ASAM医生也将接受调查，并与ASAM成员进行比较，以确定从后者队列中得出的发现的普遍性。拟议的研究将解决以下具体目的： 目的1：描述成瘾医学医师对丙型肝炎治疗的资格准则的知识和态度，并确定这些态度与医师提供的丙型肝炎治疗与DUS的相关性，无论是直接还是通过转诊）； 目的2：确定成瘾医学中医生提供的艾滋病毒护理与对DU的丙型肝炎治疗DU之间的关联，直接或转诊； 目的3：确定在药物治疗计划中的现场初级医疗服务的可用性与成瘾医学医生的DUS（直接或转诊）的丙型肝炎治疗之间的相关性。 该调查将重点介绍医师围绕治疗资格标准的知识和态度，例如对药物和酒精使用的禁欲以及抑郁史的戒酒持续时间。它将通过推荐或直接管理本身以及获得治疗资源的使用，以询问他们对吸毒者接受丙型肝炎治疗的经验。它还将询问他们的临床实践环境和专业背景。 拟议的研究将确定成瘾医学医生向吸毒者提供丙型肝炎医疗保健方面的优势和劣势，它将专注于收集对旨在改善药物使用者使用乙型肝炎治疗的干预措施有用的数据。这项研究的数据将与药物滥用治疗政策和临床实践有关。